Highlander Capital Management’s Biogen BIIB Stock Holding History

Highlander Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$112K	–	608
2021 Q1	$112K	Buy	400 +200	+100%	+$53.9K	0.06%	200
2020 Q4	$49K	Hold	200	–	–	0.03%	294
2020 Q3	$57K	Buy	+200	New	+$55.8K	0.03%	257
2016 Q4	–	Sell	-200	Closed	-$63K	–	769
2016 Q3	$63K	Hold	200	–	–	0.06%	307
2016 Q2	$48K	Buy	+200	New	+$52.7K	0.04%	359

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Highlander Capital Management's BIIB Position: Q2 2021 in Review

Highlander Capital Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 400 shares — an estimated $112K sold.

Highlander Capital Management first reported a position in BIIB in Q2 2016 and held it in 5 quarters. The position peaked at $112K in Q1 2021. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Highlander Capital Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Highlander Capital Management sold 400 Biogen shares in Q2 2021, an estimated $112K.
Highlander Capital Management first reported a position in Biogen in Q2 2016 and held it in 5 quarters.
Highlander Capital Management's Biogen position peaked at $112K in Q1 2021.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Highlander Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.